Federated Hermes, Inc. Bausch Health Companies Inc. Transaction History

Federated Hermes, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $195,268 - $392,668	-42,635 Reduced 50.66%	41,525 $286,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $170,357 - $570,191	-24,130 Reduced 22.28%	84,160 $704,000
Q1 2022 May 13, 2022	SELL	$21.6 - $27.79 $1.79 Million - $2.3 Million	-82,670 Reduced 43.29%	108,290 $2.47 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $217,580 - $274,434	9,460 Added 5.21%	190,960 $5.27 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $609,348 - $731,510	24,335 Added 15.48%	181,500 $5.06 Million
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $302,690 - $360,844	-11,035 Reduced 6.56%	157,165 $4.61 Million
Q1 2021 May 13, 2021	BUY	$21.37 - $34.38 $571,220 - $918,977	26,730 Added 18.89%	168,200 $5.34 Million
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $33,375 - $46,041	2,180 Added 1.57%	141,470 $2.94 Million
Q3 2020 Nov 12, 2020	BUY	$14.88 - $20.13 $2.07 Million - $2.8 Million	139,290 New	139,290 $2.17 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.